Skip to main content

Advertisement

SpringerLink
Log in

Antiviral market overview

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Author information

Authors and Affiliations

  1. Pharmaceuticals and Biotechnology Consultants at Wood Mackenzie, Kintore House, 74–77 Queen Street, Edinburgh, EH2 4NS, UK

    David Milroy & James Featherstone

Authors
  1. David Milroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Featherstone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James Featherstone.

Related links

Related links

DATABASES

Medscape DrugInfo

Crixivan

Hivid

interferon-α

Kaletra

Retrovir

Synagis

Videx

Viracept

FURTHER INFORMATION

FDA

Wood MacKenzie

World Health Organization

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milroy, D., Featherstone, J. Antiviral market overview. Nat Rev Drug Discov 1, 11–12 (2002). https://doi.org/10.1038/nrd709

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd709

  • Springer Nature Limited

This article is cited by

Search

Navigation